For citations:
Alekseev B.Ya., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D. Second-line hormonal therapy with the enzalutamid in patients with castrate-resistant prostate cancer. Cancer Urology. 2016;12(3):87-95. https://doi.org/10.17650/1726-9776-2016-12-3-87-95